Skip to main content
Erschienen in: Journal of Interventional Cardiac Electrophysiology 1/2012

01.01.2012

Elimination of phrenic nerve stimulation occurring during CRT

Follow-up in patients implanted with a novel quadripolar pacing lead

verfasst von: Paresh A. Mehta, Anoop K. Shetty, Mark Squirrel, Julian Bostock, C. Aldo Rinaldi

Erschienen in: Journal of Interventional Cardiac Electrophysiology | Ausgabe 1/2012

Einloggen, um Zugang zu erhalten

Abstract

Background

Phrenic nerve stimulation (PNS) occurs at follow-up in approximately 20% of patients with bipolar leads. The quadripolar Quartet model 1458Q (St. Jude Medical, Sylmar, CA, USA) left ventricular lead (LV) has four electrodes (one distal tip and three ring) capable of ten different pacing vectors which may allow reprogramming to eliminate PNS.

Methods

Forty patients underwent attempted CRT-D implantation between October 2009 and October 2010 with the Quartet lead. Pacing parameters, lead position, complications and presence of PNS were collected at implant, pre-discharge and at 3 and 6 months follow-up.

Results

A quadripolar LV lead was successfully implanted in 95% (38/40) of patients. During follow-up, one patient (3%) had a lead displacement requiring reposition. LV pacing parameters remained stable at 6 months follow-up (mean threshold 1.3 V at 0.6 ms and impedance 948 Ω). PNS at the time of implant was observed in 12 patients (32%) all of which were overcome by using the additional vectors available on the quadripolar LV lead or by repositioning the lead at the time of index implant. During 6 months follow-up there were five (13%) cases of PNS, all of which were successfully treated by reprogramming to a different vector. No cases required reintervention, surgical epicardial lead placement, or that lead be turned off.

Conclusion

The quadripolar Quartet lead is associated with a high implant success rate, stable pacing parameters and a low displacement rate during the first 6 months after implant. The ten LV pacing vectors available with this lead allowed PNS and capture threshold problems to be overcome at implant, and importantly at follow-up, thus obviating the need for lead reposition.
Literatur
1.
Zurück zum Zitat Levy, D., Kenchaiah, S., Larson, M. G., Benjamin, E. J., Kupka, M. J., Ho, K. K., et al. (2002). Long-term trends in the incidence of and survival with heart failure. The New England Journal of Medicine, 347(18), 1397–1402.PubMedCrossRef Levy, D., Kenchaiah, S., Larson, M. G., Benjamin, E. J., Kupka, M. J., Ho, K. K., et al. (2002). Long-term trends in the incidence of and survival with heart failure. The New England Journal of Medicine, 347(18), 1397–1402.PubMedCrossRef
2.
Zurück zum Zitat Mehta, P. A., Dubrey, S. W., McIntyre, H. F., Walker, D. M., Hardman, S. M., Sutton, G. C., et al. (2009). Improving survival in the six months after diagnosis of heart failure in the past decade: Population-based data from the UK. Heart, Jul 8. Mehta, P. A., Dubrey, S. W., McIntyre, H. F., Walker, D. M., Hardman, S. M., Sutton, G. C., et al. (2009). Improving survival in the six months after diagnosis of heart failure in the past decade: Population-based data from the UK. Heart, Jul 8.
3.
Zurück zum Zitat Cleland, J. G., Daubert, J. C., Erdmann, E., Freemantle, N., Gras, D., Kappenberger, L., et al. (2005). The effect of cardiac resynchronization on morbidity and mortality in heart failure. The New England Journal of Medicine, 352(15), 1539–1549.PubMedCrossRef Cleland, J. G., Daubert, J. C., Erdmann, E., Freemantle, N., Gras, D., Kappenberger, L., et al. (2005). The effect of cardiac resynchronization on morbidity and mortality in heart failure. The New England Journal of Medicine, 352(15), 1539–1549.PubMedCrossRef
4.
Zurück zum Zitat Bristow, M. R., Saxon, L. A., Boehmer, J., Krueger, S., Kass, D. A., De Marco, T., et al. (2004). Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure. The New England Journal of Medicine, 350(21), 2140–2150.PubMedCrossRef Bristow, M. R., Saxon, L. A., Boehmer, J., Krueger, S., Kass, D. A., De Marco, T., et al. (2004). Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure. The New England Journal of Medicine, 350(21), 2140–2150.PubMedCrossRef
5.
Zurück zum Zitat Abraham, W. T., Fisher, W. G., Smith, A. L., et al. (2002). Cardiac resynchronization in chronic heart failure. The New England Journal of Medicine, 346, 1845–1853.PubMedCrossRef Abraham, W. T., Fisher, W. G., Smith, A. L., et al. (2002). Cardiac resynchronization in chronic heart failure. The New England Journal of Medicine, 346, 1845–1853.PubMedCrossRef
6.
Zurück zum Zitat Moss, A. J., Hall, W. J., Cannom, D. S., Klein, H., Brown, M. W., Daubert, J. P., et al. (2009). Cardiac-resynchronization therapy for the prevention of heart-failure events. The New England Journal of Medicine, 361(14), 1329–1338.PubMedCrossRef Moss, A. J., Hall, W. J., Cannom, D. S., Klein, H., Brown, M. W., Daubert, J. P., et al. (2009). Cardiac-resynchronization therapy for the prevention of heart-failure events. The New England Journal of Medicine, 361(14), 1329–1338.PubMedCrossRef
7.
Zurück zum Zitat Biffi, M., Moschini, C., Bertini, M., Saporito, D., Ziacchi, M., Diemberger, I., et al. (2009). Phrenic stimulation: a challenge for cardiac resynchronization therapy. Circulation. Arrhythmia and Electrophysiology, 2(4), 402–410.PubMedCrossRef Biffi, M., Moschini, C., Bertini, M., Saporito, D., Ziacchi, M., Diemberger, I., et al. (2009). Phrenic stimulation: a challenge for cardiac resynchronization therapy. Circulation. Arrhythmia and Electrophysiology, 2(4), 402–410.PubMedCrossRef
8.
Zurück zum Zitat Bisch, L., Da, C. A., Dauphinot, V., Romeyer-Bouchard, C., Khris, L., M’baye, A., et al. (2010). Predictive factors of difficult implantation procedure in cardiac resynchronization therapy. Europace, 12(8), 1141–1148.PubMedCrossRef Bisch, L., Da, C. A., Dauphinot, V., Romeyer-Bouchard, C., Khris, L., M’baye, A., et al. (2010). Predictive factors of difficult implantation procedure in cardiac resynchronization therapy. Europace, 12(8), 1141–1148.PubMedCrossRef
9.
Zurück zum Zitat Dickstein, K., Cohen-Solal, A., Filippatos, G., McMurray, J. J., Ponikowski, P., Poole-Wilson, P. A., et al. (2008). ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM). European Heart Journal, 29(19), 2388–2442.PubMedCrossRef Dickstein, K., Cohen-Solal, A., Filippatos, G., McMurray, J. J., Ponikowski, P., Poole-Wilson, P. A., et al. (2008). ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM). European Heart Journal, 29(19), 2388–2442.PubMedCrossRef
10.
Zurück zum Zitat Dickstein, K., Vardas, P. E., Auricchio, A., Daubert, J. C., Linde, C., McMurray, J., et al. (2010). Focused Update of ESC Guidelines on device therapy in heart failure: an update of the 2008 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure and the 2007 ESC Guidelines for cardiac and resynchronization therapy. Developed with the special contribution of the Heart Failure Association and the European Heart Rhythm Association. European Heart Journal, 31(21), 2677–2687.PubMedCrossRef Dickstein, K., Vardas, P. E., Auricchio, A., Daubert, J. C., Linde, C., McMurray, J., et al. (2010). Focused Update of ESC Guidelines on device therapy in heart failure: an update of the 2008 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure and the 2007 ESC Guidelines for cardiac and resynchronization therapy. Developed with the special contribution of the Heart Failure Association and the European Heart Rhythm Association. European Heart Journal, 31(21), 2677–2687.PubMedCrossRef
11.
Zurück zum Zitat Shetty, A. K., Duckett, S. G., Bostock, J., Roy, D., Ginks, M., Hamid, S., et al. (2011). Initial single-center experience of a quadripolar pacing lead for cardiac resynchronization therapy. Pacing and Clinical Electrophysiology, 34(4), 484–489.PubMedCrossRef Shetty, A. K., Duckett, S. G., Bostock, J., Roy, D., Ginks, M., Hamid, S., et al. (2011). Initial single-center experience of a quadripolar pacing lead for cardiac resynchronization therapy. Pacing and Clinical Electrophysiology, 34(4), 484–489.PubMedCrossRef
12.
Zurück zum Zitat Shetty, A. K., Duckett, S. G., Bostock, J., Rosenthal, E., Rinaldi, C. A. (2011). Use of a quadripolar left ventricular lead to achieve successful implantation in patients with previous failed attempts at cardiac resynchronization therapy. Europace, Feb 22. Shetty, A. K., Duckett, S. G., Bostock, J., Rosenthal, E., Rinaldi, C. A. (2011). Use of a quadripolar left ventricular lead to achieve successful implantation in patients with previous failed attempts at cardiac resynchronization therapy. Europace, Feb 22.
13.
Zurück zum Zitat Burger, H., Schwarz, T., Ehrlich, W., Sperzel, J., Kloevekorn, W. P., & Ziegelhoeffer, T. (2011). New generation of transvenous left ventricular leads—first experience with implantation of multipolar left ventricular leads. Experimental and Clinical Cardiology, 16(1), 23–26.PubMed Burger, H., Schwarz, T., Ehrlich, W., Sperzel, J., Kloevekorn, W. P., & Ziegelhoeffer, T. (2011). New generation of transvenous left ventricular leads—first experience with implantation of multipolar left ventricular leads. Experimental and Clinical Cardiology, 16(1), 23–26.PubMed
14.
Zurück zum Zitat Forleo, G. B., la Rocca, D. G., Papavasileiou, L. P., Molfetta, A. D., Santini, L., & Romeo, F. (2011). Left ventricular pacing with a new quadripolar transvenous lead for CRT: early results of a prospective comparison with conventional implant outcomes. Heart Rhythm, 8(1), 31–37.PubMedCrossRef Forleo, G. B., la Rocca, D. G., Papavasileiou, L. P., Molfetta, A. D., Santini, L., & Romeo, F. (2011). Left ventricular pacing with a new quadripolar transvenous lead for CRT: early results of a prospective comparison with conventional implant outcomes. Heart Rhythm, 8(1), 31–37.PubMedCrossRef
15.
Zurück zum Zitat Singh, J. P., Klein, H. U., Huang, D. T., Reek, S., Kuniss, M., Quesada, A., et al. (2011). Left ventricular lead position and clinical outcome in the multicenter automatic defibrillator implantation trial-cardiac resynchronization therapy (MADIT-CRT) trial. Circulation, 123(11), 1159–1166.PubMedCrossRef Singh, J. P., Klein, H. U., Huang, D. T., Reek, S., Kuniss, M., Quesada, A., et al. (2011). Left ventricular lead position and clinical outcome in the multicenter automatic defibrillator implantation trial-cardiac resynchronization therapy (MADIT-CRT) trial. Circulation, 123(11), 1159–1166.PubMedCrossRef
Metadaten
Titel
Elimination of phrenic nerve stimulation occurring during CRT
Follow-up in patients implanted with a novel quadripolar pacing lead
verfasst von
Paresh A. Mehta
Anoop K. Shetty
Mark Squirrel
Julian Bostock
C. Aldo Rinaldi
Publikationsdatum
01.01.2012
Verlag
Springer US
Erschienen in
Journal of Interventional Cardiac Electrophysiology / Ausgabe 1/2012
Print ISSN: 1383-875X
Elektronische ISSN: 1572-8595
DOI
https://doi.org/10.1007/s10840-011-9598-5

Weitere Artikel der Ausgabe 1/2012

Journal of Interventional Cardiac Electrophysiology 1/2012 Zur Ausgabe

Nach Herzinfarkt mit Typ-1-Diabetes schlechtere Karten als mit Typ 2?

29.05.2024 Herzinfarkt Nachrichten

Bei Menschen mit Typ-2-Diabetes sind die Chancen, einen Myokardinfarkt zu überleben, in den letzten 15 Jahren deutlich gestiegen – nicht jedoch bei Betroffenen mit Typ 1.

Erhöhtes Risiko fürs Herz unter Checkpointhemmer-Therapie

28.05.2024 Nebenwirkungen der Krebstherapie Nachrichten

Kardiotoxische Nebenwirkungen einer Therapie mit Immuncheckpointhemmern mögen selten sein – wenn sie aber auftreten, wird es für Patienten oft lebensgefährlich. Voruntersuchung und Monitoring sind daher obligat.

GLP-1-Agonisten können Fortschreiten diabetischer Retinopathie begünstigen

24.05.2024 Diabetische Retinopathie Nachrichten

Möglicherweise hängt es von der Art der Diabetesmedikamente ab, wie hoch das Risiko der Betroffenen ist, dass sich sehkraftgefährdende Komplikationen verschlimmern.

TAVI versus Klappenchirurgie: Neue Vergleichsstudie sorgt für Erstaunen

21.05.2024 TAVI Nachrichten

Bei schwerer Aortenstenose und obstruktiver KHK empfehlen die Leitlinien derzeit eine chirurgische Kombi-Behandlung aus Klappenersatz plus Bypass-OP. Diese Empfehlung wird allerdings jetzt durch eine aktuelle Studie infrage gestellt – mit überraschender Deutlichkeit.

Update Kardiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.